این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Basic Medical Sciences، جلد ۲۵، شماره ۹، صفحات ۱۱۱۷-۱۱۲۲
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Intracerebroventricular injection of ghrelin receptor antagonist alleviated NAFLD via improving hypothalamic insulin resistance
چکیده انگلیسی مقاله Objective(s): Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of clinical metabolic syndrome. Insulin resistance is an important factor in the pathogenesis of NAFLD. Ghrelin, widely distributed in peripheral tissues and the central nervous system, plays a vital role in regulating food intake, energy balance, and substance metabolism. In this study, the effect of intracerebroventricular (ICV) injection of ghrelin receptor antagonist on NAFLD was explored.Materials and Methods: A rat model of NAFLD was established by feeding a high-fat diet, and a selective ghrelin receptor antagonist [D-Lys-3]-GHRP-6 was injected via ventricular intubation implantation. The serum total cholesterol (TC), triglycerides (TGs), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and hepatic TGs were measured using the colorimetric method. Fasting plasma glucose (FPG) and fasting plasma insulin (FPI) were determined to calculate homeostatic model assessment insulin resistance (HOMA-IR). Hematoxylin-eosin (HE) and Oil Red O staining were conducted to observe the pathological changes and lipid accumulation in the liver. Hosphatidylinositide3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway protein expressions were measured using western blot analysis.Results: ICV injection of [D-Lys-3]-GHRP-6 significantly reduced serum lipids, transaminase, and HOMA-IR, improved liver injury, and inhibited lipid accumulation in the liver of NAFLD rats. Moreover, ICV injection of [D-Lys-3]-GHRP-6 significantly up-regulated the phosphorylation levels of PI3K/Akt/mTOR signaling protein expressions in the hypothalamus, indicating a significant improvement in hypothalamic insulin resistance.Conclusion: Blockade of central ghrelin receptor can treat NAFLD possibly via the hypothalamic PI3K/Akt/mTOR signaling pathway to improve insulin resistance.
کلیدواژه‌های انگلیسی مقاله ghrelin, Hypothalamus, insulin resistance, NAFLD, PI3K/Akt/mTOR
نویسندگان مقاله | Yating Gong
Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China


| Yaoyao Guo
Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China


| Yiming Jiang
Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China


| Zhiyang Xing
Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China


| Heng Zhang
Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China


| Hongbo Wang
Gastrointestinal Surgery Department, Jimo District People’s Hospital, Qingdao, China


| Yanling Gong
Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China
نشانی اینترنتی https://ijbms.mums.ac.ir/article_20843.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات